Table 1.

Participants’ characteristics and pharmacological regimen.

Variable	Total	Control Group	Exercise Group
Age (years)	63.29 ± 7.20	63.88 ± 7.62	62.05 ± 6.14
Diabetes duration (years)	10.88 ± 5.48	11.32 ± 5.26	9.98 ± 5.88
Number of individuals	n = 124	n = 85	n = 39
Female	n = 64	n = 44	n = 20
Male	n = 60	n = 41	n = 19
Oral antidiabetics	n = 115 (92.74%)	n = 79 (92.94%)	n = 36 (92.31%)
Insulin	n = 50 (40.32%)	n = 35 (41.18%)	n = 15 (38.46%)
Antihypertensives	n = 102 (82.26%)	n = 71 (83.53%)	n = 31 (79.49%)
Lipid lowering agents	n = 79 (63.71%)	n = 55 (64.71%)	n = 24 (61.54%)